Evidence map›Paper›PMID 28435399›Full record

ArticleContemporary oncology (Poznan, Poland)2017

Serum atrial natriuretic peptide: a suspected biomarker of breast cancer.

Maha E Houssen, Hayam F Ghazy, Kamel Farag, Mona Abo Bakr El-Hussiny, Mohamed A El Ghaffar, Sahar Alsayed Mohamed Alsayed, Omar Farouk

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Contemporary oncology (Poznan, Poland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Resistance and Overcoming Resistance in Breast Cancer.Breast cancer (Dove Medical Press) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Maha E HoussenDepartment of Biochemistry, Faculty of Pharmacy, Damanhour University, Egypt.
Hayam F GhazyDepartment of Medical Oncology, Faculty of Medicine, Mansoura University, Egypt.
Kamel FaragDepartment of Medical Oncology, Faculty of Medicine, Mansoura University, Egypt.
Mona Abo Bakr El-HussinyDepartment of Clinical Pathology, Faculty of Medicine, Mansoura University, Egypt.
Mohamed A El GhaffarDepartment of Surgical Oncology, Faculty of Medicine, Mansoura University, Egypt.
Sahar Alsayed Mohamed AlsayedDepartment of Clinical Pathology, Faculty of Medicine, Mansoura University, Egypt.
Omar FaroukDepartment of Surgical Oncology, Faculty of Medicine, Mansoura University, Egypt.
Mansoura University · EGDamanhour University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aim of the studyTo assess serum levels of ANP in breast cancer female patients and its relationship to metastasis and some clinical parameters among those patients. MATERIAL AND

methodsOne hundred breast cancer patients with and without metastasis along with 20 healthy closely matched controls, were enrolled in the present cross sectional study. Background: To assess the serum levels of atrial natriuretic peptide in breast cancer Serum levels of ANP were assessed using ELISA.

resultsMean serum levels of ANP breast cancer patients (13.9 ±10.1 ng/ml) were significantly elevated compared to healthy control group (2.2 ±1.3 ng/ml) (

conclusionsThis study showed significant elevated levels of ANP in the serum of metastatic breast cancer patients compared to non-metastatic patients. Within the metastatic group the lowest levels were detected in metastatic breast Cancer under hormonal treatment either tamoxifen or aromatase inhibitor.

Indexed as

atrial natriuretic peptidebreast cancermetastases

Identifiers

PMID28435399
PMCPMC5385479
OpenAlexW2599589360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.